New antibodies may lead to universal Ebola vaccine, reveals study

HOUSTON: Scientists have identified three naturally-occurring Ebola antibodies which could be used to design universal therapeutics that are effective against many different species of the deadly virus.

The Ebola virus causes a severe illness with high mortality rates in humans, according to the study published in the journal ‘Nature Microbiology’.

Signs and symptoms typically start between two days and three weeks after contracting the virus with a fever, sore throat, muscular pain, and headaches.

Several strategies have been developed to treat Ebola infection, including ZMapp, which has been shown to be effective in non-human primates and has been used under compassionate-treatment protocols in humans.

“The trouble with ZMapp is that although it is effective against the Ebola species that was largely responsible for the last Ebola outbreak, it does not neutralise other Ebola species, including Ebola Bundibugyo, Reston or Sudan,” said Alex Bukreyev, a professor at University…

Read More



Please enter your comment!
Please enter your name here